Proteomic Biomarkers for the Prediction of Transition to Psychosis in Individuals at Clinical High Risk: A Multi-cohort Model Development Study
Schizophrenia Bulletin · 2024
DOI: 10.1093/schbul/sbad184 ↗Kurz gefasst
Fachartikel in der Zeitschrift Schizophrenia Bulletin, 2024. Verfasst von Jonah F Byrne und 39 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin, Ireland. Hauptthemen laut MEDLINE: Psychotic Disorders, Biomarkers, Proteomics, Prodromal Symptoms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, Science Foundation Ireland, NIMH NIH HHS.
Abstract (Originalsprache)
Psychosis risk prediction is one of the leading challenges in psychiatry. Previous investigations have suggested that plasma proteomic data may be useful in accurately predicting transition to psychosis in individuals at clinical high risk (CHR). We hypothesized that an a priori-specified proteomic prediction model would have strong predictive accuracy for psychosis risk and aimed to replicate longitudinal associations between plasma proteins and transition to psychosis. This study used plasma samples from participants in 3 CHR cohorts: the North American Prodrome Longitudinal Studies 2 and 3, and the NEURAPRO randomized control trial (total n = 754). Plasma proteomic data were quantified using mass spectrometry. The primary outcome was transition to psychosis over the study follow-up period. Logistic regression models were internally validated, and optimism-corrected performance metrics derived with a bootstrap procedure. In the overall sample of CHR participants (age: 18.5, SD: 3.9; 51.9% male), 20.4% (n = 154) developed psychosis within 4.4 years. The a priori-specified model showed poor risk-prediction accuracy for the development of psychosis (C-statistic: 0.51 [95% CI: 0.50, 0.59], calibration slope: 0.45). At a group level, Complement C8B, C4B, C5, and leucine-rich α-2 glycoprotein 1 (LRG1) were associated with transition to psychosis but did not surpass correction for multiple comparisons. This study did not confirm the findings from a previous proteomic prediction model of transition from CHR to psychosis. Certain complement proteins may be weakly associated with transition at a group level. Previous findings, derived from small samples, should be interpreted with caution.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin, Ireland.
- SFI FutureNeuro Research Centre, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin, Ireland.
- Department of Psychology, Royal College of Surgeons in Ireland, Dublin 2, Ireland.
- Centre for Public Health, Queen's University Belfast, Belfast, UK.
- School of Biomolecular and Biomedical Science, Conway Institute, University College Dublin, Dublin, Ireland.
- School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Wales, UK.
ORCID-Profile: Jonah F Byrne, Colm Healy, David Mongan, Anita Riecher-Rössler, William S Stone, Carrie E Bearden, Elaine F Walker, Gerard Cagney
Förderung
- NCATS NIH HHS
- Science Foundation Ireland
- NIMH NIH HHS
- National Institute of Mental Health
- Stanley Medical Research Institute
- National Health and Medical Research Council
- Colonial Foundation
Zitieren
APA
Byrne, J. F., Healy, C., Föcking, M., Susai, S. R., Mongan, D., Wynne, K., Kodosaki, E., Heurich, M., de Haan, L., Hickie, I. B., Smesny, S., Thompson, A., Markulev, C., Young, A. R., Schäfer, M. R., Riecher-Rössler, A., Mossaheb, N., Berger, G., Schlögelhofer, M., …, & Cotter, D. R. (2024). Proteomic Biomarkers for the Prediction of Transition to Psychosis in Individuals at Clinical High Risk: A Multi-cohort Model Development Study. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbad184
Vancouver
Byrne JF, Healy C, Föcking M, Susai SR, Mongan D, Wynne K, et al. Proteomic Biomarkers for the Prediction of Transition to Psychosis in Individuals at Clinical High Risk: A Multi-cohort Model Development Study. Schizophrenia Bulletin. 2024. doi:10.1093/schbul/sbad184
BibTeX
@article{Byrne2024,
author = {Byrne, Jonah F and Healy, Colm and Föcking, Melanie and Susai, Subash Raj and Mongan, David and Wynne, Kieran and Kodosaki, Eleftheria and Heurich, Meike and de Haan, Lieuwe and Hickie, Ian B and Smesny, Stefan and Thompson, Andrew and Markulev, Connie and Young, Alison Ruth and Schäfer, Miriam R and Riecher-Rössler, Anita and Mossaheb, Nilufar and Berger, Gregor and Schlögelhofer, Monika and Nordentoft, Merete and Chen, Eric Y H and Verma, Swapna and Nieman, Dorien H and Woods, Scott W and Cornblatt, Barbara A and Stone, William S and Mathalon, Daniel H and Bearden, Carrie E and Cadenhead, Kristin S and Addington, Jean and Walker, Elaine F and Cannon, Tyrone D and Cannon, Mary and McGorry, Pat and Amminger, Paul and Cagney, Gerard and Nelson, Barnaby and Jeffries, Clark and Perkins, Diana and Cotter, David R},
title = {Proteomic Biomarkers for the Prediction of Transition to Psychosis in Individuals at Clinical High Risk: A Multi-cohort Model Development Study},
journal = {Schizophrenia Bulletin},
year = {2024},
doi = {10.1093/schbul/sbad184}
}
EUVIMED